Drawing for REVERSE TRANSLATIONAL MEDICINE

USPTO serial 85984179

REVERSE TRANSLATIONAL MEDICINE

Reviewed by CopyMark Law Group

Reg. 5188931Status 705Renewal
Filing date
Status date
Registration date
Apr 25, 2017
Examiner
LEHKER, DAWN FELDMAN
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with REVERSE TRANSLATIONAL MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janice Housey

4 Weems Lane #240Winchester, VA 22601United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; diagnostic preparations for medical and veterinary use; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases ]SECTION 8 - CANCELLED—
042Testing, inspection or research of pharmaceuticals, [ cosmetics or foodstuffs; ] Consultation and providing information about testing, inspection or research of pharmaceuticals, [ cosmetics or foodstuffs; ] providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research [ ; computer hardware design and development; computer software design and development ]ACTIVE—
044[ Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 19, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 19, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 12, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 12, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 12, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 15, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 15, 2023C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 15, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 15, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Apr 25, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 21, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 21, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 21, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 21, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 25, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2017ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 1, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 1, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 28, 2016IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 4, 2016ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Aug 4, 2016PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Jul 13, 2016DPCCDIVISIONAL PROCESSING COMPLETE—
Jul 8, 2016APETASSIGNED TO PETITION STAFF—
Jun 22, 2016DRRRDIVISIONAL REQUEST RECEIVED—
Jun 22, 2016TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Jun 10, 2016UNTDREQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN—
Jun 7, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 26, 2016ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Apr 23, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2016EX4GSOU EXTENSION 4 GRANTED—
Apr 21, 2016EXT4SOU EXTENSION 4 FILED—
Apr 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 15, 2015EX3GSOU EXTENSION 3 GRANTED—
Oct 14, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 7, 2015EXT3SOU EXTENSION 3 FILED—
Oct 7, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2015EX2GSOU EXTENSION 2 GRANTED—
May 16, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 15, 2015EXT2SOU EXTENSION 2 FILED—
Apr 15, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 17, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2014EX1GSOU EXTENSION 1 GRANTED—
Jun 13, 2014EXT1SOU EXTENSION 1 FILED—
Jun 13, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 11, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 5, 2014ALIEASSIGNED TO LIE—
Feb 5, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Feb 5, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 5, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 5, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 4, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 20, 2013PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 7, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 7, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 28, 2013ALIEASSIGNED TO LIE—
Sep 17, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 13, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2012DOCKASSIGNED TO EXAMINER—
Jun 28, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 23, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance